⏳ Final hours! Save up to 60% OFF InvestingProCLAIM SALE

Orthofix Medical Inc (OFIX)

NASDAQ
Currency in USD
18.95
-0.39(-2.02%)
Real-time Data
OFIX Scorecard
Full Analysis
2 analysts have revised their earnings downwards for the upcoming period
Fair Value
Day's Range
18.8919.40
52 wk Range
10.4620.73
Key Statistics
Edit
Prev. Close
19.34
Open
19.39
Day's Range
18.89-19.4
52 wk Range
10.46-20.73
Volume
26.67K
Average Volume (3m)
261.63K
1-Year Change
79.24%
Book Value / Share
unlockUnlock
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
OFIX Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
24.40
Upside
+28.08%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year
Show more

Orthofix Medical Inc Company Profile

Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

Orthofix Medical Inc SWOT Analysis


Merger Momentum
Orthofix's integration with SeaSpine drives growth, with Q2 revenues surpassing expectations and improved guidance for 2024
Segment Strengths
Bone Growth Therapies leads with double-digit growth, while Spinal Implants and Global Orthopedics show steady progress
Financial Turnaround
Orthofix anticipates positive free cash flow in H2 2024, earlier than expected, signaling improved operational efficiency
Analyst Perspectives
Roth MKM sets $20 price target, while JMP Securities maintains Market Perform rating, reflecting mixed outlook on profitability
Read full SWOT analysis
OFIX Full Pro Research
Institutional-Grade Stock Analysis
Understand how OFIX earns money
Financial health at a glance
Bearish and bullish outlooks
Latest expert insights
Actionable Pro Tips, and many more...
Gain access to 1400+ in-depth research reports on the most popular US stocks

Orthofix Medical Inc Earnings Call Summary for Q4/2024

  • Q3 net sales up 7% YoY to $196.6M; U.S. spine fixation grew 18%, driven by new products Reef and WaveForm
  • 2027 targets: 6-7% CAGR in net sales, mid-teens adjusted EBITDA margins; 8-9% of sales invested annually in R&D
  • 2024 net sales projected at $795-800M, up to 7.2% growth; completed $275M financing to optimize capital structure
  • Strong performance across Spine franchises; record 7D navigation system agreements, critical for navigated procedures
  • Developing MIS solution for ASC expansion; 7D system demand increasing due to efficiency and quick registration times
Last Updated: 2024/11/11, 11:50
Read Full Transcript

Compare OFIX to Peers and Sector

Metrics to compare
OFIX
Peers
Sector
Relationship
P/E Ratio
−6.1x−8.5x−0.7x
PEG Ratio
−0.25−0.080.00
Price/Book
1.4x3.4x2.6x
Price / LTM Sales
0.9x3.3x3.2x
Upside (Analyst Target)
24.1%42.2%46.4%
Fair Value Upside
Unlock−4.3%6.9%Unlock

Analysts' Recommendations

3 Buy
2 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 24.40

(+28.76% Upside)

FAQ

What Is the Orthofix (OFIX) Stock Price Today?

The Orthofix stock price today is 18.95

What Stock Exchange Does Orthofix Trade On?

Orthofix is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Orthofix?

The stock symbol for Orthofix is "OFIX."

What Is the Orthofix Market Cap?

As of today, Orthofix market cap is 727.60M.

What is Orthofix Earnings Per Share?

The Orthofix EPS is -3.15.

What Is the Next Orthofix Earnings Date?

Orthofix will release its next earnings report on 02 Mar 2025.

From a Technical Analysis Perspective, Is OFIX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.